Light and Shadow of Na-Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Points for Improvement Based on Our Clinical Experience

<div>HbA1c histogram at the beginning of treatment (upper middle graph) and after six months (graphs (a)–(f)). Columns from (a) to (f) in the upper figure show the histogram of HbA1c at the start of treatment. The histograms six months after treatment were redrawn below. (a) to (f) histograms show the detailed changes in HbA1c.</div>

International Journal of Endocrinology

fig4

Figure 4

Figure 4: Light and Shadow of Na-Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Points for Improvement Based on Our Clinical Experience 

Figure 4 | Light and Shadow of Na-Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Points for Improvement Based on Our Clinical Experience 